SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is trending following strong earnings results, with investors focusing on the company's revenue beat and raised guidance. Community discussions revolve around the impressive EPS growth and bullish outlook, while some traders express regret over missed opportunities. The stock's performance is also being viewed in the context of its competition with Oracle and its growing presence in AI.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid's stock is trending downwards as investors express concerns about the company's financial health and leadership, despite positive reviews of their vehicles. The community is actively discussing the potential for reverse splits, bankruptcy, and the impact of Saudi Arabian investments. Some traders see potential for short squeezes or are employing strategies based on historical data, while others express frustration with the company's performance and management.

Fly-E Group, Inc. is an electric vehicle company, which engages in designing, installing, and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the brand Fly E-Bike. Its products include electric-scooter, e-bikes, parts, and accessories. The company was founded by Zhou Ou in 2018 and is headquartered in Flushing, NY.

Fly-E Group Inc.

Fly-E Group Inc

Fly-E Group is trending due to high volatility and speculation of a potential short squeeze, evidenced by a massive increase in trading volume. The community is actively discussing dark pool short interest and debating whether the stock can repeat the dramatic moves of similar plays, while others warn of the risks associated with pump-and-dump schemes and the company's fundamentals.

Meet Pandu — your AI friend who’s always by your side. Talk with him in real time through text or voice, share your thoughts, ask questions, or just enjoy a casual conversation. Whether you’re looking for advice, company, or simply someone to listen, Pandu is here as a true companion you can connect with anytime.  Pandu unites real-time conversation, creative generation, and future-ready AI systems — all powered by next-gen technology.

Pandu Pandas

Pandu Pandas ($PANDU) is trending as the community rallies around its potential within the Solana ecosystem, citing a low market cap and growing holder base as key factors. The community highlights upcoming announcements and consistent development as reasons for optimism, with some drawing comparisons to other successful memecoins on $SOL. Some users are pointing to NFTs and exchange listings as potential catalysts.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

RIGL is trending due to upcoming data presentations at the ASH conference, particularly for its IRAK1/4 inhibitor R289, with potential implications for the lucrative MDS market. Community discussions revolve around buyout potential, low P/E ratio, and speculation about short positions ahead of these events. Bullish sentiment is fueled by institutional ownership and revenue growth, while some traders eye options and potential short squeezes.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending amid discussions about its valuation, pipeline, and recent acquisition of Astria Therapeutics, with the community debating short interest and potential catalysts. Investor sentiment appears mixed, with some expressing frustration over the stock's performance, while others highlight its revenue growth and potential in the HAE market. A key upcoming event is the FDA decision on Orladeyo for pediatric use.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

OPGN is trending as the community discusses its potential as an AI-driven fintech platform following investment from AEI Capital; some are speculating about a possible Nasdaq relisting and future price targets while noting the company's previous focus on medical devices. Chatter revolves around the launch of the CapForce platform and expectations for significant upside, with some looking back at past reverse splits while maintaining hope for a turnaround.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as its community rallies around a meme-focused culture and a self-proclaimed "infection." The community emphasizes their organic growth and active engagement, dismissing 

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

ARWR is trending following positive analyst sentiment and community excitement surrounding its RNAi platform and deep pipeline, especially after a recent deal with Novartis. Discussions highlight the potential for multiple upcoming catalysts, including data readouts and a PDUFA date, to significantly increase the company's valuation. Some investors believe ARWR may outperform its peers.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is trending after a strong earnings report, with a significant revenue surge driven by AI infrastructure demand. Community members are actively discussing the company's growth potential and future outlook, while some debate its valuation. Overall, the focus remains on Credo's role in the high-speed connectivity space for AI and data centers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Marker Therapeutics (NASDAQ:MRKR)  Shares Down 2.7%

Marker Therapeutics, Inc. (NASDAQ:MRKR - Get Free Report)'s share price traded down 2.7% on Friday . The company traded as low as $4.66 and last traded at $4.75. 31,276 shares traded hands during...

Marker Therapeutics Advances in Immuno-Oncology

Marker Therapeutics (MRKR) has released an update. Marker Therapeutics has announced significant strides in its immuno-oncology programs, including...

Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results

Lead program in patients with lymphoma demonstrated preliminary safety and efficacy results with sustained complete response in first study participant treated with MT-601 (Neldaleucel) following CAR...

Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

HOUSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies...

Marker Therapeutics Ends Stock Sale Deal with LPC

An announcement from Marker Therapeutics Inc (MRKR) is now available. Marker Therapeutics, Inc. has terminated its stock sale agreement with Lincol...

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for  Neldaleucel  as Nonproprietary Name for MT-601

HOUSTON, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for...

Marker Therapeutics (NASDAQ:MRKR) Shares Up 0.4%

Marker Therapeutics, Inc. (NASDAQ:MRKR  Get Free Report)s stock price shot up 0.4% on Tuesday . The company traded as high as $5.00 and last traded at $4.96. 28,057 shares were traded...

Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization

Strategic prioritization of clinical programs with focus on MT-601 in patients with lymphoma MultiTAA-specific T cell therapies demonstrate clinical safety and positive clinical data across multiple...

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its multi-tumor associated antigen (multiTAA)-specific T cell product...

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Marker Therapeutics Inc

$CRWD

$CRM

$SNOW

$MDB

Which earnings report are you most looking forward to this week? 
 
Drop a comment for others.

MRKR
Marker Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MRKR News

MRKRMarker Therapeutics Inc